We present a 46-year-old female smoker who was admitted to the emergency department of our hospital due to cough with blood-tinged sputum for the last four days before admission. Using echocardiography and Multi-Detector Computed Tomography (MDCT) heart Echinococcosis was diagnosed. Echinococcosis is a severe health issue in some geographical regions of the world. Hydatid infection of the heart is rare and the clinical presentation is usually insidious but there is always the lethal hazard of cyst perforation. Early diagnosis and an integrated treatment strategy are crucial. The results of surgical treatment of heart echinococcosis are better than the conservative strategy only. Extraction of the cyst combined with chemotherapy peri or post operative aiming to decrease the recurrences, consists the lege artis method of encountering this medical entity. Surgical excision was performed and the patient had an uneventful recovery and follow up at six and twelve months.
[Purpose] This study was aimed to investigate the effects of Ergon
®
IASTM
applications on the upper or lower part of the Superficial Back Line (SBL) on the
hamstring’s flexibility. [Participants and Methods] Sixty University students (age=24.4 ±
4.39; height=176.78 ± 8.31 cm; weight=75.16 ± 11.21 kg) were randomly divided into three
sub-groups and received a single 15-minute treatment with Ergon
®
Technique in
a) the upper and b) the lower part of SBL or c) served as control. The participants
received one treatment per week for four weeks with a simultaneous pre-and post-therapy
assessment of their hamstrings flexibility using the passive Straight Leg Raising (SLR).
[Results] Both experimental groups improved SLR performance from pre to post during the
four weeks from 4.4% to 9.2% in the trunk group and from 4.9% to 8.0% in the lower body
group. These differences were significantly greater from the CTRL group. No differences
were observed between the two experimental groups. [Conclusion] In conclusion, application
of Ergon Technique of either the upper or lower part of the SBL may lead to a significant
increase in the hamstring flexibility irrespective of the site of application.
This study aimed to evaluate the posterior thigh's skin thermal responses to 448-kHz radiofrequency-based therapy applied either in the form of standard application (Indiba ® Activ) or combined soft tissue treatment (Indiba ® Fascia treatment). [Participants and Methods] Ten healthy males (22 ± 3 years of age, weight 75.2 ± 4.9 kg, height 178.5 ± 4.7) received four different treatments which included a) Indiba ® Activ (IA) radiofrequency treatment, b) Indiba ® Fascia (IF), c) Indiba ® Activ placebo (IAP) and d) Indiba ® Fascia Placebo (IFP) in the posterior thigh of their dominant lower limb, while the non-dominant served as the control. Skin temperature was recorded pre-and post-treatment and every minute until the surface temperature reached pre-treatment levels using a wireless infrared thermometer. [Results] Both radiofrequency-based therapy groups IA and IF led to a significant increase in skin temperature compared to placebo applications. The IF intervention led to an average retention of elevated temperature for 164.2 minutes compared to 54.8 minutes of IA, 23.17 of IFP and 17.6 minutes of IAP. [Conclusion] These findings indicate that radiofrequency treatment at 448 kHz can induce and sustain significant thermal skin adaptations reflecting an increased blood circulation and metabolism of underlying tissues.
The findings of this study suggest that tumor cervical cells evade normal growth control by sex steroid hormones while synchronously abnormal regulatory mechanisms acquire control of the cell cycle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.